Visit other SMART + STRONG sites:
POZREAL HEALTHTU SALUD
Subscribe to:
E-newsletters
POZ magazine
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » Top Stories

Most Popular Stories
HIV Eradication: One Step Closer
Life Expectancy With HIV Increases Dramatically
Mouth Full of Problems: A Crisis in HIV Dental Care
New Technology Finds Meds That Might Flush Out Hidden HIV Reservoirs
New Hope for HIV Eradication
Personalized Therapeutic Vaccine Shows Promise
What's That Mean?
(just double-click it!)

If you don't understand one of the words in this article, just double-click it. A window will open with a definition from mondofacto's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:

Most Popular Lessons
The HIV Life Cycle
Shingles
Herpes Simplex Virus
Syphilis & Neurosyphilis
Treatments for Opportunistic Infections (OIs)
What is AIDS & HIV?
More News

Have medical or treatment news about HIV? Send press releases, news tips and other announcements to editors@aidsmeds.com.

Click here for more news


emailrssprint

June 23, 2008

HIV Hospitalizations Halved Since 1994

Hospitalizations for any cause in people living with HIV decreased by more than half between 1994 and 2005, according to a study published in the July 11 issue of AIDS.

The death rate has dropped substantially since the introduction in 1995 and 1996 of triple-combination antiretroviral (ARV) therapy. To determine the effect of ARV therapy on hospitalizations, Kate Buchacz, PhD, from the Centers for Disease Control and Prevention in Atlanta, and her colleagues examined the medical records of 7,155 patients enrolled in the HIV Outpatient Study (HOPS) between 1994 and 2005.

Over the course of the study, 2,141 people were hospitalized a total of 4,735 times. The overall rate of hospitalizations fell by more than half between 1994 and 2005. Even more dramatic, there were nearly eight times fewer hospitalizations for AIDS-related opportunistic infections in 2005 than in 1994. The reduction in hospitalizations occurred equally for men and women and among people of different races and ethnicities. Rates of hospitalizations for non-AIDS-related causes remained the same over time.

Buchacz’s team also found that lowest ever CD4 count (nadir) and current CD4 count had an impact on hospitalizations both before and after the introduction of triple-combination ARV regimens. People with the lowest nadir and current CD4 counts were most likely to be hospitalized, leading the authors to comment that perhaps earlier initiation of ARV therapy may result in even fewer hospitalizations.

Search: hospitalization, antiretroviral, Kate Buchacz, Centers for Disease Control, CDC, HOPS, opportunistic infection


Scroll down to comment on this story.

emailrssprint

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The AIDSmeds team review all comments before they are posted. Please do not include ":" "@" "<" ">" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

| Posting Rules

Previous Comments:

       


[Go to top]

Quick Links
AIDSmeds en Español
About HIV and AIDS
Lab Tests
My Cool Tools
HIV Meds
Starting Treatment
Switching Treatment
Drug Resistance
Side Effects
Disclosure
Lipodystrophy
Hepatitis & HIV
Women & Children
Fact Sheets
Treatment News
Community Forums
Blogs
Conference Coverage
Health Services Directory
POZ Magazine
Conference Coverage

CROI 2009
Montréal, Canada
February 8-11, 2009


48th Annual ICAAC/IDSA 46th Annual Meeting
Washington, DC
October 25-28, 2008


XVII International AIDS Conference
Mexico City, Mexico
August 3-8, 2008


more conference coverage


[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2009 Smart + Strong. All Rights Reserved. Terms of use and Your privacy